Sir Paul Nurse awarded Weizmann Honorary Doctorate

Paul Nurse Hon Phd Web
Sir Paul Nurse receiving his Honorary PhD from Prof Daniel Zajfman, President of the Weizmann Institute

We were delighted that Sir Paul Nurse, Director of the Francis Crick Institute was last month among the six recipients of honorary doctorates bestowed this year by the Weizmann Institute of Science as part of the 70th Annual General Meeting of the International Board.

Sir Paul Nurse is a Nobel Prize-winning geneticist and cell biologist whose research findings on cell growth and division have broad implications for the study of cancer and other diseases. He discovered cdc2, a gene that plays a pivotal role in cell cycle progression. A former President of New York’s Rockefeller University, he served as President of the Royal Society between 2010-2015, and currently is Director of the Executive Committee of London’s Francis Crick Institute. Sir Paul is an ardent supporter of advancing relations between the U.K. and Israel.

Sir Paul Nurse also gave the keynote address at the Annual Luncheon marking the presentation of the Sir Charles Clore Prize.

Other highlights of the International Board Meeting included the announcement of the Dangoor Chair of Archaeological Sciences supported by Judy and David Dangoor. The incumbent of the Chair is Prof Elisabetta Boaretto, Scientific Archaeology Unit.

Judy and David Dangoor with Prof Elisabetta Boaretto


Published: December 11, 2018

Apply to Our Education Programmes

Applications for the International Summer Science Institute 2019 are open until Monday 25 February.

Apply now

Leave a Legacy

By leaving a gift to Weizmann UK in your will you can enable scientists at the Weizmann Institute to continue their ground breaking research.

Find out More

Read our Impact Stories

Weizmann UK provides funding to the Weizmann Institute of Science in very large part thanks to the support and vision of our extraordinary donors. Find out more about why our donors support us and the impact their generous gifts have.

Find out More